CEO Ingrid Zhang buys $163,200 of Legend Biotech Corp stock
The CEO paid an average of $8.16 a share, according to a Form 4 filed with the SEC on Nov 20.
A Form 4 filed on Nov 20 shows Ingrid Zhang (CEO) buying 20,000 Legend Biotech Corp shares worth $163,200 on Nov 17.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. It is the second insider purchase at Legend Biotech Corp reported in the last 90 days.
It is the insider's first open-market purchase of LEGN in at least 12 months. After the trade, the filing lists 1,151,860 shares held.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Legend Biotech Corp (LEGN) |
|---|---|
| Insider | Ingrid Zhang |
| Role | CEO |
| Transaction | Open-market purchase (code P) |
| Shares | 20,000 |
| Average price | $8.16 |
| Value | $163,200 |
| Trade date | Nov 17, 2026 |
| Filed with the SEC | Nov 20, 2026, 4:10 PM ET |
| Shares held after | 1,151,860 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
View this Form 4 in Insider Stock Trader
Read more LEGN insider trading news · See the latest cluster buys and sells
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.